NCT03790488 - Study of a PD-1 Inhibitor (JTX-4014) in Subjects With Solid Tumor Malignancies | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 6, 2018

Primary Completion Date

July 2, 2019

Study Completion Date

February 28, 2023

Conditions

Cancer

Interventions

DRUG

JTX-4014

Specified dose on specified days

Trial Locations (4)

Florida Cancer Specialists - Sarasota Cattlemen, Sarasota

START Midwest - Cancer & Hematology Centers of Western Michigan, Grand Rapids

South Texas Accelerated Research Therapeutics (START), San Antonio

Sarah Cannon Research Institute at HealthONE, Denver